Acorn Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $498K | Sell |
1,979
-43
| -2% | -$9.25K | 0.12% | 162 |
|
|
2026
Q1 | $440K | Sell |
2,022
-4
| -0.2% | -$887 | 0.13% | 151 |
|
|
2025
Q4 | $463K | Sell |
2,026
-117
| -5% | -$26.7K | 0.14% | 144 |
|
|
2025
Q3 | $496K | Buy |
2,143
+176
| +9% | +$35.8K | 0.16% | 142 |
|
|
2025
Q2 | $365K | Sell |
1,967
-22
| -1% | -$4.09K | 0.14% | 151 |
|
|
2025
Q1 | $417K | Sell |
1,989
-36
| -2% | -$7K | 0.17% | 125 |
|
|
2024
Q4 | $360K | Sell |
2,025
-64
| -3% | -$11.8K | 0.15% | 135 |
|
|
2024
Q3 | $413K | Sell |
2,089
-173
| -8% | -$32.3K | 0.18% | 116 |
|
|
2024
Q2 | $388K | Buy |
2,262
+425
| +23% | +$70.4K | 0.19% | 106 |
|
|
2024
Q1 | $335K | Buy |
1,837
+80
| +5% | +$13.8K | 0.17% | 122 |
|
|
2023
Q4 | $272K | Sell |
1,757
-128
| -7% | -$18.7K | 0.16% | 142 |
|
|
2023
Q3 | $281K | Sell |
1,885
-112
| -6% | -$16.4K | 0.19% | 125 |
|
|
2023
Q2 | $269K | Sell |
1,997
-19
| -0.9% | -$2.79K | 0.18% | 135 |
|
|
2023
Q1 | $321K | Sell |
2,016
-17
| -0.8% | -$2.6K | 0.24% | 101 |
|
|
2022
Q4 | $329K | Buy |
2,033
+35
| +2% | +$5.37K | 0.25% | 93 |
|
|
2022
Q3 | $268K | Sell |
1,998
-38
| -2% | -$5.45K | 0.22% | 111 |
|
|
2022
Q2 | $312K | Sell |
2,036
-104
| -5% | -$15.9K | 0.25% | 109 |
|
|
2022
Q1 | $347K | Sell |
2,140
-124
| -5% | -$18K | 0.24% | 109 |
|
|
2021
Q4 | $307K | Buy |
2,264
+61
| +3% | +$7.21K | 0.19% | 129 |
|
|
2021
Q3 | $238K | Sell |
2,203
-124
| -5% | -$14.2K | 0.17% | 145 |
|
|
2021
Q2 | $262K | Buy |
2,327
+68
| +3% | +$7.66K | 0.18% | 131 |
|
|
2021
Q1 | $244K | Sell |
2,259
-32
| -1% | -$3.42K | 0.17% | 134 |
|
|
2020
Q4 | $245K | Sell |
2,291
-334
| -13% | -$32.1K | 0.19% | 124 |
|
|
2020
Q3 | $230K | Buy |
2,625
+497
| +23% | +$46.8K | 0.2% | 108 |
|
|
2020
Q2 | $209K | Buy |
+2,128
| New | +$187K | 0.19% | 111 |
|
|
2018
Q3 | – | Sell |
-716
| Closed | -$67K | – | 119 |
|
|
2018
Q2 | $67K | Sell |
716
-9
| -1% | -$879 | 0.06% | 220 |
|
|
2018
Q1 | $71K | Sell |
725
-510
| -41% | -$56K | 0.06% | 207 |
|
|
2017
Q4 | $123K | Buy |
+1,235
| New | +$116K | 0.11% | 146 |
|
Other funds holding ABBV
Acorn Wealth Advisors's ABBV Position: Q2 2026 in Review
Acorn Wealth Advisors reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $9.25K and leaving 1,979 shares worth $498K. The position accounts for 0.12% of the portfolio, ranked #162.
Acorn Wealth Advisors first reported a position in ABBV in Q4 2017 and has held it in 28 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Acorn Wealth Advisors held 1,979 shares of AbbVie worth $498K as of Q2 2026.
- Acorn Wealth Advisors sold 43 AbbVie shares in Q2 2026, an estimated $9.25K.
- AbbVie made up 0.12% of Acorn Wealth Advisors's portfolio in Q2 2026, its #162 holding.
- Acorn Wealth Advisors first reported a position in AbbVie in Q4 2017 and has held it in 28 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Acorn Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.